Literature DB >> 18490756

PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes.

Jared H Rowe1, Tanner M Johanns, James M Ertelt, Sing Sing Way.   

Abstract

Infection with attenuated Listeria monocytogenes (Lm) is a robust in vivo model for examining how Ag-specific T cells are primed, and subsequent challenge with virulent Lm allows for the protective effects of T cell priming to be quantified. Herein, we investigated the role of programmed death ligand 1 (PDL-1) in T cell priming and immunity conferred after primary infection with Lm DeltaactA followed by virulent Lm challenge. In striking contrast to the inhibitory role of PDL-1 on T cell immunity in other infection models, marked reductions in the magnitude of T cell expansion and the kinetics of T cell proliferation were observed with PDL-1 blockade after primary Lm DeltaactA infection. More importantly, PDL-1 blockade beginning before primary infection and maintained throughout the experiment resulted in delayed bacterial clearance and T cell expansion after secondary challenge with virulent Lm. These results indicate that for immunity to intracellular bacterial infection, PDL-1 plays an important stimulatory role for priming and expansion of protective T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490756      PMCID: PMC2677094          DOI: 10.4049/jimmunol.180.11.7553

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Vaginal protection and immunity after oral immunization of mice with a novel vaccine strain of Listeria monocytogenes expressing human immunodeficiency virus type 1 gag.

Authors:  Xinyan Zhao; Manxin Zhang; Zhongxia Li; Fred R Frankel
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  PD-1 and its ligands in T-cell immunity.

Authors:  Mary E Keir; Loise M Francisco; Arlene H Sharpe
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

3.  PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver.

Authors:  Holly Maier; Masanori Isogawa; Gordon J Freeman; Francis V Chisari
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

4.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.

Authors:  Lydie Trautmann; Loury Janbazian; Nicolas Chomont; Elias A Said; Sylvain Gimmig; Benoit Bessette; Mohamed-Rachid Boulassel; Eric Delwart; Homero Sepulveda; Robert S Balderas; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Nat Med       Date:  2006-08-20       Impact factor: 53.440

5.  IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection.

Authors:  Sing Sing Way; Colin Havenar-Daughton; Ganesh A Kolumam; Nural N Orgun; Kaja Murali-Krishna
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

6.  Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection.

Authors:  Mark T Orr; Nural N Orgun; Christopher B Wilson; Sing Sing Way
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

7.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

8.  PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.

Authors:  Simona Urbani; Barbara Amadei; Daniela Tola; Marco Massari; Simona Schivazappa; Gabriele Missale; Carlo Ferrari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 9.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

10.  Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection.

Authors:  Su-Kil Seo; Hye-Young Jeong; Sae-Gwang Park; Soo-Woong Lee; Il-Whan Choi; Lieping Chen; Inhak Choi
Journal:  Immunology       Date:  2007-10-25       Impact factor: 7.397

View more
  45 in total

1.  T cell and APC dynamics in situ control the outcome of vaccination.

Authors:  Kamal M Khanna; David A Blair; Anthony T Vella; Stephen J McSorley; Sandip K Datta; Leo Lefrançois
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection.

Authors:  Beth McNally; Fang Ye; Meredith Willette; Emilio Flaño
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

3.  Foxp3+ regulatory T cells impede the priming of protective CD8+ T cells.

Authors:  James M Ertelt; Jared H Rowe; Margaret A Mysz; Charanjeet Singh; Monika Roychowdhury; Marijo N Aguilera; Sing Sing Way
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

Review 4.  Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy.

Authors:  Zahra Rashidijahanabad; Xuefei Huang
Journal:  Semin Immunol       Date:  2020-01-22       Impact factor: 11.130

Review 5.  Inhibitory receptors on lymphocytes: insights from infections.

Authors:  Pamela M Odorizzi; E John Wherry
Journal:  J Immunol       Date:  2012-04-01       Impact factor: 5.422

6.  Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection.

Authors:  Thomas D Norton; Takuya Tada; Rebecca Leibowitz; Verena van der Heide; Dirk Homann; Nathaniel R Landau
Journal:  Mol Ther       Date:  2020-05-20       Impact factor: 11.454

7.  Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis.

Authors:  Eszter Lázár-Molnár; Bing Chen; Kari A Sweeney; Emilie J Wang; Weijun Liu; Juan Lin; Steven A Porcelli; Steven C Almo; Stanley G Nathenson; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

8.  PD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis.

Authors:  Sarah C Fankhauser; Michael N Starnbach
Journal:  J Immunol       Date:  2013-12-18       Impact factor: 5.422

Review 9.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.

Authors:  Maria Del Castillo; Fabian A Romero; Esther Argüello; Chrisann Kyi; Michael A Postow; Gil Redelman-Sidi
Journal:  Clin Infect Dis       Date:  2016-08-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.